Michelle L. Basil

2021

In 2021, Michelle L. Basil earned a total compensation of $2.1M as Executive Vice President, General Counsel at Haemonetics, a 16% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$325,364
Option Awards$299,996
Salary$474,204
Stock Awards$1,019,211
Other$16,137
Total$2,134,912

Basil received $1M in stock awards, accounting for 48% of the total pay in 2021.

Basil also received $325.4K in non-equity incentive plan, $300K in option awards, $474.2K in salary and $16.1K in other compensation.

Rankings

In 2021, Michelle L. Basil's compensation ranked 5,807th out of 12,415 executives tracked by ExecPay. In other words, Basil earned more than 53.2% of executives.

ClassificationRankingPercentile
All
5,807
out of 12,415
53rd
Division
Manufacturing
2,461
out of 5,505
55th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
305
out of 801
62nd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
183
out of 522
65th
Industry
Surgical and Medical Instruments and Apparatus
118
out of 327
64th

Pay ratio

Michelle L. Basil's Pay$2,134,912
Median Employee's Pay$39,767
Pay Ratio

54

to 1

In 2021, the annual total compensation of Michelle L. Basil was $2,134,912.

The annual total compensation of the median employee at Haemonetics was $39,767.

The ratio of Michelle L. Basil's pay to the pay of median employee was therefore 54 to one.

Source: SEC filing on June 17, 2021.

Basil's colleagues

We found four more compensation records of executives who worked with Michelle L. Basil at Haemonetics in 2021.

2021

Christopher Simon

Haemonetics

Chief Executive Officer

2021

William Burke

Haemonetics

Chief Financial Officer

2021

Anila Lingamneni

Haemonetics

Executive Vice President, Chief Technogy Officer

2021

Josep Llorens

Haemonetics

Senior Vice President, Global Manufacturing and Supply Chain

News

You may also like